Cambridge Healthtech Institute

Transcription

1 Cambridge Healthtech Institute Your Life Science Network Conference & Course Catalog March August 2016 CHI is a division of Cambridge Innovation Institute RESEARCH COLLABORATION ADVANCEMENT

2 TABLE OF CONTENTS CONFERENCE SERIES Biological Therapeutic Products... 4 Biomarkers and... 4 Bioprocess and Manufacturing... 5 Clinical Trials & Translational Medicine... 6 Chemistry... 6 BioPharmaceutical Strategy... 6 Drug Discovery & Development... 7 Drug Targets... 7 Genomics... 8 Healthcare... 8 Informatics and IT... 9 Therapeutic Indications... 9 Technology and Tools for Life Sciences...10 CONFERENCES BY DATE WITH DETAIL SHORT COURSE SCHEDULE About Cambridge Healthtech Institute For over 20 years, Cambridge Healthtech Institute has developed more than 800 conferences, which have attracted over 60,000 attendees from around the world. CHI is the industry leader in offering quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments in the life science industry. Leading researchers and business experts from top pharmaceutical, biotech, and academic organizations present their most current findings in a forum that features panel discussions and audience participation. Each year, CHI organizes over 170 annual events geared to the biotech and pharmaceutical industries with specific focuses on Biomarkers, Genomics, Proteins and Proteomics, Drug Discovery & Development, IT and Informatics, Chemistry, & Safety, and Business. For a comprehensive listing and detailed information about our products and services, please visit: healthtech.com. Follow youtube.com/user/cambridgehealthtech CONTACT US CUSTOMER SERVICE Pamela Gerardi Director of Customer Service E: pgerardi@healthech.com T: Kris Waterman Sr. Customer Service Representative E: kwaterman@healthtech.com T: Rose LaRaia Customer Service Representative E: rlaraia@healthtech.com T: MARKETING Jim MacNeil Vice President of Marketing E: jmacneil@healthtech.com T: Rich Handy Senior Director of Marketing E: rhandy@healthtech.com T: SPONSOR & EXHIBIT SALES Angela Parsons Vice President of Business Development E: aparsons@healthtech.com T: Carol Dinerstein Director, Business Development E: dinerstein@healthtech.com T: GROUP SALES David Cunningham Director, Inside Sales E: cunningham@healthtech.com T: GRAPHICS Thomas Norton Design Director E: tnorton@healthtech.com T: PRODUCTION Edel O Regan, Ph.D. Vice President of Production E: eoregan@healthtech.com T: Christina Lingham Executive Director of Conferences E: clingham@healthtech.com T: Mary Ann Brown Executive Director of Conferences E: mabrown@healthtech.com T: Julia Boguslavsky Executive Director of Conferences E: juliab@healthtech.com T: Micah Lieberman Executive Director of Conferences E: mlieberman@healthtech.com T: linkedin.com/company/cambridge-healthtech-institute Cambridge Healthtech Institute 250 First Avenue, Suite 300 Needham, MA T: (781) or Toll-free in the U.S F: (781) Cambridge Healthtech Institute

3 2016 KEY EVENTS The Protein Science Week January 18-22, 2016 Town and Country Resort & Convention Center San Diego, CA CHI-PepTalk.com April 5-7, 2016 Seaport World Trade Center Boston, MA Bio-ITWorldExpo.com BIOMARKERS & DIAGNOSTICS WORLD CONGRESS May 17-19, 2016 Philadelphia Downtown Marriott Philadelphia, PA BiomarkerWorldCongress.com Summit for Clinical Trials Ops Executives February 23-25, 2016 Hyatt Regency Miami Miami, FL SCOPESummit.com March 6-11, 2016 Moscone North Convention Center San Francisco, CA TriConference.com Drug Discovery Chemistry BOSTON The Essential Protein Engineering Summit April 19-22, 2016 Hilton San Diego Resort San Diego, CA DrugDiscoveryChemistry.com April 25-29, 2016 Seaport World Trade Center Boston, MA PEGSummit.com THE June 14-17, 2016 Westin Boston Waterfront Boston, MA WorldPreclinicalCongress.com BIOPROCESSING SUMMIT August 15-19, 2016 Westin Boston Waterfront Boston, MA BioprocessingSummit.com EUROPE The Essential Protein Engineering Summit August 23-26, 2016 Grand Hyatt Washington Washington, DC NextGenerationDx.com September Westin Boston Waterfront Boston, MA DiscoveryonTarget.com October 31-November 4, 2016 EPIC SANA Lisboa Hotel Lisbon, Portugal PEGSummitEurope.com ONE STOP SHOP AFFILIATED REPORTS COLLECTION for Over 1,000 Life Science Reports Spanning over 50 Research Areas An Essential Collection of Timely & Concise Reports Analyzing the Technologies, Markets, and Strategic Issues Driving R&D Productivity. Available through Insight Pharma Reports and our Network of Affiliated Reports. Insight Pharma Reports offers: 4 Market Data 4 Market Research 4 Pipeline Data 4 Custom Reports 4 Clinical Trial Data 4 Bundled Report Packages For more information, contact Daniel Miller at: DMiller@InsightPharmaReports.com or call (781) InsightPharmaReports.com Just some of the Reports Available Include: Alzheimer s Disease Biomarkers & BioPharma Strategy Biosimilars & Generic Markets Cancer Research and Therapeutics Chemistry Clinical Trials & Translational Medicine Data Mining Drug Discovery & Development Health IT Infectious Disease Medical Devices Multiple Sclerosis Ocular Pain Management Pharmaceutical Marketing Sequencing Vaccines...and many others March August

4 Conferences by Series Biological Therapeutic Products Predictive Preclinical Models in Oncology Biomarkers for Cancer Immunotherapy Cancer Biotherapeutics March 14-16, 2016 Boston, MA Immuno-Oncology March 14-15, 2016 London, UK Novel Approaches for Cancer March 15-16, 2016 London, UK Developability and Candidate Selection March 14-15, 2016 Bethesda, MD Advances in Characterization Methods and Approaches March 16-17, 2016 Bethesda, MD Comparability and Biosimilarity March 17-18, 2016 Bethesda, MD PEGS China Summit April 5-7, 2016 Pudong Shanghai Protein and Antibody Engineering April 5-6, 2016 Pudong Shanghai Analytical Characterization and Biotherapeutics April 5-6, 2016 Pudong Shanghai Next-Generation Cancer Biotherapeutics April 6-7, 2016 Pudong Shanghai Clinical Development and Regulatory Requirements April 6-7, 2016 Pudong Shanghai Protein Aggregation and Stability April 6-7, 2016 Pudong Shanghai Clinical and Regulatory Strategies for Domestic and Global IND and BLA Filings April 6-7, 2016 Pudong Shanghai Drug Discovery Chemistry April 19-22, 2016 San Diego, CA Phage and Yeast Display of Antibodies April 25-26, 2016 Boston, MA Difficult to Express Proteins April 25-26, 2016 Boston, MA Biologics for Autoimmune Diseases April 25-26, 2016 Boston, MA Characterization of Biotherapeutics April 25-26, 2016 Boston, MA Antibodies for Cancer Therapy April 25-26, 2016 Boston, MA Immunogenicity: Regulatory and Clinical Case Studies April 25-26, 2016 Boston, MA Preventing Toxicity in Immunotherapy April 25-26, 2016 Boston, MA Fusion Protein Therapeutics April 25-26, 2016 Boston, MA Biophysical Analysis of Biotherapeutics April 27-28, 2016 Boston, MA Strategies for Immunogenicity Assay Assessment April 27-28, 2016 Boston, MA Antibody-Drug Conjugates I: New Ligands, Payloads and Alternative Formats April 27-28, 2016 Boston, MA Advancing Bispecific Antibodies and Combination Therapy to the Clinic April 27-28, 2016 Boston, MA Adoptive T Cell Therapy April 27-28, 2016 Boston, MA Biologics and Vaccines for Infectious Diseases April 27-28, 2016 Boston, MA Protein Aggregation and Stability in Biopharmaceuticals April 28-29, 2016 Boston, MA Engineering Bispecific Antibodies April 28-29, 2016 Boston, MA Agonist Immunotherapy Targets April 28-29, 2016 Boston, MA Antibody-Drug Conjugates II: Advancing Toward the Clinic April 28-29, 2016 Boston, MA Optimizing Bioassays for Biologics April 28-29, 2016 Boston, MA Cancer Immunotherapy and Combinations Blood-Brain Barrier Targeting Membrane Proteins Tumor Models for Cancer Immunotherapy Rapid Methods to Assess Quality and Stability of Biologics August 15-16, 2016 Boston, MA Cell Therapy CMC, Quality and Analytics August 15-16, 2016 Boston, MA Early Analytical Development for Biotherapeutics August 17-18, 2016 Boston, MA Cell Therapy Bioproduction, Operations and Logistics August 17-18, 2016 Boston, MA High-Concentration Protein Formulations August 18-19, 2016 Boston, MA Process Characterization, Qualification and Control August 18-19, 2016 Boston, MA Gene Therapy Bioproduction August 18-19, 2016 Boston, MA to Guide Cancer Immunotherapy August 24-25, 2016 Washington, DC Molecular Medicine Tri-Con March 6-11, 2016 San Francisco, CA PCR for Molecular Medicine Genomic Sample Prep and Biomarker Assay Development Digital Pathology 4 Cambridge Healthtech Institute Molecular Precision Medicine Molecular for Infectious Disease Personalized Cancer Molecular Markers Circulating Tumor Cells Predictive Preclinical Models in Oncology Circulating Cell-Free DNA Companion

5 Point-of-Care Biomarkers for Cancer Immunotherapy Commercialization of Molecular microrna as Biomarkers and April 4-5, 2016 Cambridge, MA Molecular Europe April 4-7, 2016 Lisboa, Portugal Advances in Prenatal Molecular April 4-6, 2016 Lisboa, Portugal Circulating Tumour Cells April 5-6, 2016 Lisboa, Portugal Circulating Cell-Free DNA April 6-7, 2016 Lisboa, Portugal Reproductive Genetic April 6-7, 2016 Lisboa, Portugal Point-of-Care April 6-7, 2016 Lisboa, Portugal Extracellular RNA in Drug and Diagnostic Development April 5-6, 2016 Cambridge, MA Bio-IT World Bioinformatics Exosomes and Microvesicles as Biomarkers and May 16, 2016 Philadelphia, PA Biomarkers & World Congress May 17-19, 2016 Philadelphia, PA Big Data for Personalized Medicine and Biomarker Discovery May 17-18, 2016 Philadelphia, PA Cell-Free Biomarkers and May 17-18, 2016 Philadelphia, PA Biomarkers for Patient Selection May 17-18, 2016 Philadelphia, PA Clinical and Translational Biomarkers in Drug Development May 18-19, 2016 Philadelphia, PA Companion May 18-19, 2016 Philadelphia, PA Biomarkers for Cancer Immunotherapy May 18-19, 2016 Philadelphia, PA Latest Advances in Nano-Oncology June 14, 2016 Boston, MA Applying Pharmacology to New Drug Development June 15, 2016 Boston, MA Novel Preclinical Models in Oncology Tumor Models for Cancer Immunotherapy The Liquid Biopsy Summit June 22-24, 2016 San Francisco, CA Biodefense World Summit June 27-30, 2016 Baltimore, MD Next Generation Dx Summit August 23-26, 2016 Washington, DC Enabling Point-of-Care August 23-24, 2016 Washington, DC Companion : Strategy and Partnerships August 23-24, 2016 Washington, DC Coverage and Reimbursement of Advanced August 23-24, 2016 Washington, DC Conferences by Series Clinical NGS Assays August 23-24, 2016 Washington, DC Circulating Tumor Cells August 23-24, 2016 Washington, DC DNA Forensics August 23-24, 2016 Washington, DC Hospital Laboratory Design and Renovation August 23-24, 2016 Washington, DC Molecular for Infectious Disease August 24-25, 2016 Washington, DC to Guide Cancer Immunotherapy August 24-25, 2016 Washington, DC Commercialization of Molecular August 24-25, 2016 Washington, DC Clinical Application of Cell-Free DNA August 24-25, 2016 Washington, DC Leveraging Pharmacies for Rapid August 24-25, 2016 Washington, DC NGS : Data Considerations, Annotation and Interpretation August 24-25, 2016 Washington, DC Predictive Cancer Biomarkers August 26, 2016 Washington, DC Non-Invasive Prenatal Testing August 26, 2016 Washington, DC Health and Wellness Genomic Screening August 26, 2016 Washington, DC Advances in Microbiome August 26, 2016 Washington, DC Digital PCR August 26, 2016 Washington, DC Biotherapeutics Analytical Summit March 14-18, 2016 Bethesda, MD Difficult to Express Proteins April 25-26, 2016 Boston, MA Characterization of Biotherapeutics April 25-26, 2016 Boston, MA Immunogenicity: Regulatory and Clinical Case Studies April 25-26, 2016 Boston, MA Biophysical Analysis of Biotherapeutics April 27-28, 2016 Boston, MA Strategies for Immunogenicity Assay Assessment April 27-28, 2016 Boston, MA Protein Aggregation and Stability in Biopharmaceuticals April 28-29, 2016 Boston, MA Optimizing Bioassays for Biologics April 28-29, 2016 Boston, MA Protein Expression System Engineering April 28-29, 2016 Boston, MA The Bioprocessing Summit August 15-19, 2016 Boston, MA Optimizing Cell Culture Technology August 15-16, 2016 Boston, MA Rapid Methods to Assess Quality and Stability of Biologics August 15-16, 2016 Boston, MA Continuous Processing in Biopharm Manufacturing August 15-16, 2016 Boston, MA Cell Therapy CMC, Quality and Analytics August 15-16, 2016 Boston, MA Host Cell Proteins: Detection, Analysis and Removal August 15-16, 2016 Boston, MA Manufacturing and CMC Strategies for Biologics August 15-16, 2016 Boston, MA Overcoming Formulation Challenges for Biopharmaceutical Development August 17-18, 2016 Boston, MA Bioproduction: Scale, Bioreactors and Disposables August 17-18, 2016 Boston, MA Early Analytical Development for Biotherapeutics August 17-18, 2016 Boston, MA Advances in Purification Technologies August 17-18, 2016 Boston, MA March August

6 Conferences by Series Cell Therapy Bioproduction, Operations and Logistics August 17-18, 2016 Boston, MA Virus and Pathogen Clearance and Safety in Biologics August 18-19, 2016 Boston, MA Optimizing Cell Line Development August 18-19, 2016 Boston, MA High-Concentration Protein Formulations August 18-19, 2016 Boston, MA Process Characterization, Qualification and Control August 18-19, 2016 Boston, MA Gene Therapy Bioproduction August 18-19, 2016 Boston, MA Genomic Sample Prep and Biomarker Assay Development Cancer Immunotherapy Predictive Preclinical Models in Oncology Biomarkers for Cancer Immunotherapy Cancer Biotherapeutics March 14-16, 2016 London, UK Advanced for Infectious Disease April 5-6, 2016 Lisboa, Portugal Medical Informatics World Conference April 4-5, 2016 Boston, MA BioIT World Clinical Research & Translational Informatics Cancer Informatics PEGS China Summit April 5-7, 2016 Pudong Shanghai Next-Generation Cancer Biotherapeutics April 6-7, 2016 Pudong Shanghai Clinical Development and Regulatory Requirements April 6-7, 2016 Pudong Shanghai Antibody-Drug Conjugates II: Advancing Toward the Clinic April 28-29, 2016 Boston, MA CHI s Clinical Trial Innovation Summit May 9-11, 2016 Boston, MA Mastering Risk-Based Monitoring May 9-10, 2016 Boston, MA Big Data for Clinical Trials May 9-10, 2016 Boston, MA Patient Recruitment & Site Selection May 9-10, 2016 Boston, MA Clinical Trial Auditing May 10-11, 2016 Boston, MA Outsourcing for Clinical Trials May 10-11, 2016 Boston, MA Data & Tech Driven Clinical Trials May 10-11, 2016 Boston, MA Biomarkers & World Congress May 17-19, 2016 Philadelphia, PA Cell-Free Biomarkers and May 17-18, 2016 Philadelphia, PA Biomarkers for Patient Selection May 17-18, 2016 Philadelphia, PA Clinical and Translational Biomarkers in Drug Development May 18-19, 2016 Philadelphia, PA Biomarkers for Cancer Immunotherapy May 18-19, 2016 Philadelphia, PA Latest Advances in Nano-Oncology June 14, 2016 Boston, MA Blood-Brain Barrier Companion : Strategy and Partnerships August 23-24, 2016 Washington, DC to Guide Cancer Immunotherapy August 24-25, 2016 Washington, DC Bio-IT World Drug Discovery Chemistry April 19-22, 2016 San Diego, CA Inflammation Inhibitors April 19-20, 2016 San Diego, CA Protein-Protein Interactions April 19-20, 2016 San Diego, CA Epigenetic Inhibitor Discovery April 19-20, 2016 San Diego, CA Fragment-Based Drug Discovery April 20-21, 2016 San Diego, CA Kinase Inhibitor Chemistry April 20-21, 2016 San Diego, CA Macrocyclics and Constrained Peptides April 20-21, 2016 San Diego, CA Antivirals: Small Molecules against Viral and Host Targets April 22, 2016 San Diego, CA Biophysical Approaches for Drug Discovery April 22, 2016 San Diego, CA Brain Penetrant Inhibitors April 22, 2016 San Diego, CA PEGS: The Essential Protein Engineering Summit April 25-29, 2016 Boston, MA Mastering Medicinal Chemistry Chemical Biology in Drug Discovery Property-Based Drug Design in Medicinal Chemistry Commercialization of Molecular Pharmaceutical R&D Informatics 6 Cambridge Healthtech Institute Clinical Development and Regulatory Requirements April 6-7, 2016 Pudong Shanghai Clinical and Regulatory Strategies for Domestic and Global IND and BLA Filings April 6-7, 2016 Pudong Shanghai Outsourcing for Clinical Trials May 10-11, 2016 Boston, MA Strategic Alliance Management Congress May 16-18, 2016 Philadelphia, PA Companion May 18-19, 2016 Philadelphia, PA

7 Companion : Strategy and Partnerships August 23-24, 2016 Washington, DC Coverage and Reimbursement of Advanced August 23-24, 2016 Washington, DC Conferences by Series Commercialization of Molecular August 24-25, 2016 Washington, DC Molecular Medicine Tri-Con March 6-11, 2016 San Francisco, CA Cancer Immunotherapy Predictive Preclinical Models in Oncology New Frontiers in Gene Editing Immuno-Oncology March 14-15, 2016 London, UK Novel Approaches for Cancer March 15-16, 2016 London, UK microrna as Biomarkers and April 4-5, 2016 Cambridge, MA Oligonucleotide Therapeutics and Delivery April 4-5, 2016 Cambridge, MA Extracellular RNA in Drug and Diagnostic Development April 5-6, 2016 Cambridge, MA BioIT World Pharmaceutical R&D Informatics PEGS China Summit April 5-7, 2016 Pudong Shanghai Drug Discovery Chemistry April 19-22, 2016 San Diego, CA Inflammation Inhibitors April 19-20, 2016 San Diego, CA Protein-Protein Interactions April 19-20, 2016 San Diego, CA Epigenetic Inhibitor Discovery April 19-20, 2016 San Diego, CA Fragment-Based Drug Discovery April 20-21, 2016 San Diego, CA Kinase Inhibitor Chemistry April 20-21, 2016 San Diego, CA Macrocyclics and Constrained Peptides April 20-21, 2016 San Diego, CA Drug Targets SERIES Antivirals: Small Molecules against Viral and Host Targets April 22, 2016 San Diego, CA Biophysical Approaches for Drug Discovery April 22, 2016 San Diego, CA Brain Penetrant Inhibitors April 22, 2016 San Diego, CA PEGS: The Essential Protein Engineering Summit April 25-29, 2016 Boston, MA Biologics for Autoimmune Diseases April 25-26, 2016 Boston, MA Preventing Toxicity in Immunotherapy April 25-26, 2016 Boston, MA Fusion Protein Therapeutics April 25-26, 2016 Boston, MA Adoptive T Cell Therapy April 27-28, 2016 Boston, MA Biologics and Vaccines for Infectious Diseases April 27-28, 2016 Boston, MA Agonist Immunotherapy Targets April 28-29, 2016 Boston, MA Exosomes and Microvesicles as Biomarkers and May 16, 2016 Philadelphia, PA Biomarkers & World Congress May 17-19, 2016 Philadelphia, PA Cell-Free Biomarkers and May 17-18, 2016 Philadelphia, PA Biomarkers for Patient Selection May 17-18, 2016 Philadelphia, PA Clinical and Translational Biomarkers in Drug Development May 18-19, 2016 Philadelphia, PA Biomarkers for Cancer Immunotherapy May 18-19, 2016 Philadelphia, PA World Preclinical Congress June 14-17, 2016 Boston, MA Latest Advances in Nano-Oncology June 14, 2016 Boston, MA Novel Preclinical Models in Oncology Applying Pharmacology to New Drug Development June 15, 2016 Boston, MA New Approaches for Predicting Drug Toxicity Mastering Medicinal Chemistry Cancer Immunotherapy and Combinations Advances in ips Cell Technology for Drug Development Applications Blood-Brain Barrier 3D Cellular Models Targeting Membrane Proteins Chemical Biology in Drug Discovery Tumor Models for Cancer Immunotherapy Property-Based Drug Design in Medicinal Chemistry Translational Gene Editing Companion : Strategy and Partnerships August Washington, DC to Guide Cancer Immunotherapy August 24-25, 2016 Washington, DC Cancer Immunotherapy New Frontiers in Gene Editing PEGS China Summit April 5-7, 2016 Pudong Shanghai Protein and Antibody Engineering April 5-6, 2016 Pudong Shanghai Analytical Characterization and Biotherapeutics April 5-6, 2016 Pudong Shanghai Next-Generation Cancer Biotherapeutics April 6-7, 2016 Pudong Shanghai Clinical Development and Regulatory Requirements April 6-7, 2016 Pudong Shanghai Protein Aggregation and Stability April 6-7, 2016 Pudong Shanghai Clinical and Regulatory Strategies for Domestic and Global IND and BLA Filings April 6-7, 2016 Pudong Shanghai March August

8 Conferences by Series Drug Discovery Chemistry April 19-22, 2016 San Diego, CA Inflammation Inhibitors April 19-20, 2016 San Diego, CA Protein-Protein Interactions April 19-20, 2016 San Diego, CA Epigenetic Inhibitor Discovery April 19-20, 2016 San Diego, CA Fragment-Based Drug Discovery April 20-21, 2016 San Diego, CA Kinase Inhibitor Chemistry April 20-21, 2016 San Diego, CA Macrocyclics and Constrained Peptides April 20-21, 2016 San Diego, CA Antivirals: Small Molecules against Viral and Host Targets April 22, 2016 San Diego, CA Biophysical Approaches for Drug Discovery April 22, 2016 San Diego, CA Brain Penetrant Inhibitors April 22, 2016 San Diego, CA PEGS: The Essential Protein Engineering Summit April 25-29, 2016 Boston, MA Biomarkers & World Congress May 17-19, 2016 Philadelphia, PA Latest Advances in Nano-Oncology June 14, 2016 Boston, MA Cancer Immunotherapy and Combinations 3D Cellular Models Targeting Membrane Proteins Chemical Biology in Drug Discovery Property-Based Drug Design in Medicinal Chemistry Molecular Medicine Tri-Con March 6-11, 2016 San Francisco, CA PCR for Molecular Medicine Genomic Sample Prep and Biomarker Assay Development Digital Pathology Cancer Immunotherapy Bioinformatics for Big Data Molecular Personalized Cancer Molecular Markers Predictive Preclinical Models in Oncology New Frontiers in Gene Editing Circulating Cell-Free DNA Companion Genomics & Sequencing Data Integration, Analysis and Visualization microrna as Biomarkers and April 4-5, 2016 Cambridge, MA Circulating Tumour Cells April 5-6, 2016 Lisboa, Portugal Circulating Cell-Free DNA April 6-7, 2016 Lisboa, Portugal Reproductive Genetic April 6-7, 2016 Lisboa, Portugal Quantitative Imaging Radiomics and Advanced Medical Image Analysis April 4-5, 2016 Boston, MA Extracellular RNA in Drug and Diagnostic Development April 5-6, 2016 Cambridge, MA Bioinformatics Next-Gen Sequencing Informatics Clinical Genomics Exosomes and Microvesicles as Biomarkers and May 16, 2016 Philadelphia, PA Cell-Free Biomarkers and May 17-18, 2016 Philadelphia, PA Biomarkers for Patient Selection May 17-18, 2016 Philadelphia, PA Novel Preclinical Models in Oncology Advances in ips Cell Technology for Drug Development Applications Chemical Biology in Drug Discovery Translational Gene Editing The Liquid Biopsy Summit June 22-24, 2016 San Francisco, CA Biodefense World Summit June 27-30, 2016 Baltimore, MD DNA Forensics August 23-24, 2016 Washington, DC NGS : Data Considerations, Annotation and Interpretation August 24-25, 2016 Washington, DC Non-Invasive Prenatal Testing August 26, 2016 Washington, DC Health and Wellness Genomic Screening August 26, 2016 Washington, DC Digital PCR August 26, 2016 Washington, DC Digital Pathology Precision Medicine Predictive Preclinical Models in Oncology Medical Informatics World Conference April 4-5, 2016 Boston, MA 8 Cambridge Healthtech Institute Value-Based Delivery Models and Cross- Industry Data Collaboration April 4-5, 2016 Boston, MA Coordinated Care, Patient Engagement and Connected Health April 4-5, 2016 Boston, MA Population Health Management Risk Modeling and Patient Stratification April 4-5, 2016 Boston, MA Quantitative Imaging Radiomics and Advanced Medical Image Analysis April 4-5, 2016 Boston, MA

9 Achieving Global Interoperability in Healthcare Datasets and Systems April 4-5, 2016 Boston, MA Data Visualization & Exploration Tools Coverage and Reimbursement of Advanced August 23-24, 2016 Washington, DC Conferences by Series Hospital Laboratory Design and Renovation August 23-24, 2016 Washington, DC Telemedicine August 26, 2016 Washington, DC Integrated Informatics Driving Translational Research & Precision Medicine Bioinformatics for Big Data Precision Medicine Genomics & Sequencing Data Integration, Analysis and Visualization Medical Informatics World Conference April 4-5, 2016 Boston, MA Value-Based Delivery Models and Cross- Industry Data Collaboration April 4-5, 2016 Boston, MA Coordinated Care, Patient Engagement and Connected Health April 4-5, 2016 Boston, MA Population Health Management Risk Modeling and Patient Stratification April 4-5, 2016 Boston, MA Quantitative Imaging Radiomics and Advanced Medical Image Analysis April 4-5, 2016 Boston, MA Achieving Global Interoperability in Healthcare Datasets and Systems April 4-5, 2016 Boston, MA Bio-IT World Data & Storage Management Software Applications & Services Data Computing Cloud Computing Bioinformatics Next-Gen Sequencing Informatics Open Source Innovations Cancer Informatics Data Security CHI s Clinical Trial Innovation Summit May 9-11, 2016 Boston, MA Big Data for Clinical Trials May 9-10, 2016 Boston, MA Data & Tech Driven Clinical Trials May 10-11, 2016 Boston, MA Cell-Free Biomarkers and May 17-18, 2016 Philadelphia, PA The Liquid Biopsy Summit June 22-24, 2016 San Francisco, CA NGS : Data Considerations, Annotation and Interpretation August 24-25, 2016 Washington, DC Telemedicine August 26, 2016 Washington, DC SERIES Cancer Immunotherapy New Frontiers in Gene Editing Companion Immuno-Oncology March 14-15, 2016 London, UK Novel Approaches for Cancer March 15-16, 2016 London, UK Protein and Antibody Engineering April 5-6, 2016 Pudong Shanghai Analytical Characterization and Biotherapeutics April 5-6, 2016 Pudong Shanghai Next-Generation Cancer Biotherapeutics April 6-7, 2016 Pudong Shanghai Clinical Development and Regulatory Requirements April 6-7, 2016 Pudong Shanghai Protein Aggregation and Stability April 6-7, 2016 Pudong Shanghai Clinical and Regulatory Strategies for Domestic and Global IND and BLA Filings April 6-7, 2016 Pudong Shanghai Drug Discovery Chemistry April 19-22, 2016 San Diego, CA Inflammation Inhibitors April 19-20, 2016 San Diego, CA Antivirals: Small Molecules against Viral and Host Targets April 22, 2016 San Diego, CA Brain Penetrant Inhibitors April 22, 2016 San Diego, CA Biologics for Autoimmune Diseases April 25-26, 2016 Boston, MA Antibodies for Cancer Therapy April 25-26, 2016 Boston, MA Antibody-Drug Conjugates I: New Ligands, Payloads and Alternative Formats April 27-28, 2016 Boston, MA Advancing Bispecific Antibodies and Combination Therapy to the Clinic April 27-28, 2016 Boston, MA Adoptive T Cell Therapy April 27-28, 2016 Boston, MA Agonist Immunotherapy Targets April 28-29, 2016 Boston, MA Antibody-Drug Conjugates II: Advancing Toward the Clinic April 28-29, 2016 Boston, MA Biomarkers & World Congress May 17-19, 2016 Philadelphia, PA Biomarkers for Cancer Immunotherapy May 18-19, 2016 Philadelphia, PA Latest Advances in Nano-Oncology June 14, 2016 Boston, MA Oncolytic Viruses in Cancer Therapies June 14, 2016 Boston, MA World Preclinical Congress June 14, 2016 Boston, MA Cancer Immunotherapy and Combinations Blood-Brain Barrier March August

10 Conferences by Series 3D Cellular Models Targeting Membrane Proteins Chemical Biology in Drug Discovery Molecular Medicine Tri-Con March 6-11, 2016 San Francisco, CA PCR for Molecular Medicine Genomic Sample Prep and Biomarker Assay Development Cancer Immunotherapy Bioinformatics for Big Data Molecular Precision Medicine Personalized Cancer Molecular Markers Circulating Tumor Cells Clinical NGS Clinical NGS New Frontiers in Gene Editing Point-of-Care Commercialization of Molecular Developability and Candidate Selection March 14-15, 2016 Bethesda, MD Advances in Characterization Methods and Approaches March 16-17, 2016 Bethesda, MD Comparability and Biosimilarity March 17-18, 2016 Bethesda, MD microrna as Biomarkers and April 4-5, 2016 Cambridge, MA Oligonucleotide Therapeutics and Delivery April 4-5, 2016 Cambridge, MA Circulating Tumour Cells April 5-6, 2016 Lisboa, Portugal Circulating Cell-Free DNA April 6-7, 2016 Lisboa, Portugal Extracellular RNA in Drug and Diagnostic Development April 5-6, 2016 Cambridge, MA 10 Cambridge Healthtech Institute Bio-IT World Data & Storage Management Software Applications & Services Data Computing Cloud Computing Clinical Research & Translational Informatics Data Visualization & Exploration Tools Bioinformatics Next-Gen Sequencing Informatics Pharmaceutical R&D Informatics Open Source Innovations Cancer Informatics Data Security PEGS China Summit April 5-7, 2016 Pudong Shanghai Protein and Antibody Engineering April 5-6, 2016 Pudong Shanghai Analytical Characterization and Biotherapeutics April 5-6, 2016 Pudong Shanghai Protein Aggregation and Stability April 6-7, 2016 Pudong Shanghai Drug Discovery Chemistry April 19-22, 2016 San Diego, CA Inflammation Inhibitors April 19-20, 2016 San Diego, CA Protein-Protein Interactions April 19-20, 2016 San Diego, CA Epigenetic Inhibitor Discovery April 19-20, 2016 San Diego, CA Fragment-Based Drug Discovery April 19-21, 2016 San Diego, CA Kinase Inhibitor Chemistry April 20-21, 2016 San Diego, CA Macrocyclics and Constrained Peptides April 20-21, 2016 San Diego, CA Antivirals: Small Molecules against Viral and Host Targets April 22, 2016 San Diego, CA Biophysical Approaches for Drug Discovery April 22, 2016 San Diego, CA Brain Penetrant Inhibitors April 22, 2016 San Diego, CA PEGS: The Essential Protein Engineering Summit April 25-29, 2016 Boston, MA Phage and Yeast Display of Antibodies April 25-26, 2016 Boston, MA Antibody-Drug Conjugates I: New Ligands, Payloads and Alternative Formats April 27-28, 2016 Boston, MA Antibody-Drug Conjugates II: Advancing Toward the Clinic April 28-29, 2016 Boston, MA Protein Expression System Engineering April 28-29, 2016 Boston, MA Big Data for Clinical Trials May 9-10, 2016 Boston, MA Patient Recruitment & Site Selection May 9-10, 2016 Boston, MA Data & Tech Driven Clinical Trials May 10-11, 2016 Boston, MA Biomarkers & World Congress May 17-19, 2016 Boston, MA World Preclinical Congress June 14-17, 2016 Boston, MA Novel Preclinical Models in Oncology New Approaches for Predicting Drug Toxicity Cancer Immunotherapy and Combinations Advances in ips Cell Technology for Drug Development Applications Blood-Brain Barrier 3D Cellular Models Targeting Membrane Proteins Chemical Biology in Drug Discovery Tumor Models for Cancer Immunotherapy Property-Based Drug Design in Medicinal Chemistry

11 Translational Gene Editing The Liquid Biopsy Summit June 22-24, 2016 San Francisco, CA Continuous Processing in Biopharm Manufacturing August 15-16, 2016 Boston, MA Advances in Purification Technologies August 17-18, 2016 Boston, MA Enabling Point-of-Care August 23-24, 2016 Washington, DC Clinical NGS Assays August 23-24, 2016 Washington, DC Circulating Tumor Cells August 23-24, 2016 Washington, DC DNA Forensics August 23-24, 2016 Washington, DC Clinical Application of Cell-Free DNA August 24-25, 2016 Washington, DC Conferences by Series Leveraging Pharmacies for Rapid August 24-25, 2016 Washington, DC Telemedicine August 26, 2016 Washington, DC Digital PCR August 26, 2016 Washington, DC Conferences by Date with Detail Molecular Medicine Tri-Conference March 6-11, 2016 San Francisco, CA Attracting over 3,300 drug discovery and development professionals from over 40 countries in 2015, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, and Information Technology. With a 23 year history, this year s expanded coverage includes additional programs on Molecular for Infectious Disease, Precision Medicine and Cancer Immunotherapy, as well as two new symposia on Companion and the Commercialization of Molecular. TriConference.com Biotherapeutics Analytical Summit March 14-18, 2016 Bethesda, MD In today s competitive world of myriad biologics formats and the ever increasing regulatory demands, it is imperative for companies to come up with the best and fastest way to assess a molecule s developability, develop the right assays, platforms and approaches, and ultimately establish a molecule s comparability and/or biosimilarity to ensure regulatory success. At CHI s 7th Annual Biotherapeutics Analytical Summit, we closely monitor these trends and are pleased to bring to you three timely and pertinent topics that will address Developability and Candidate Selection, Advances in Characterization Methods and Approaches, and Comparability and Biosimilarity. BiotherapeuticsAnalyticalSummit.com Cancer Biotherapeutics March 14-16, 2016 London, UK Research in Cancer Biotherapeutics is progressing in leaps and bounds with rapid and exciting developments taking place with many different approaches. Cambridge Healthtech Institute, the producer of PepTalk and PEGS Protein & Antibody Engineering Summits, are responding by introducing a European event concentrating solely on this topic. Both tracks focus strongly on immunotherapy, with case studies on immune check point inhibitors, agonistic and immunomodulatory approaches, immunocytokines, chimeric antigen receptors, retargeting T cells, immunomodulatory bispecifics, oncolytic immunotherapy, and the role of dendritic cells. We also broaden the scope with presentations on targets and lead selection, fusion proteins, ADCs, and on recreating the tumour microenvironment for translational studies. For this inaugural event we have chosen central London, knowing that this will appeal to academics and industry experts. Our venue is right beside the river in Docklands, now a very modern and vibrant location. CancerBiotherapeutics.com Oligonucleotide Therapeutics and Delivery April 4-5, 2016 Cambridge, MA Oligonucleotide based therapeutics have long formed the third major drug development platform, specifically focused on modulating gene expression by targeting RNA or the genome itself. A key distinguishing attribute of nucleic acids as therapeutic agents is their ability to access the undruggable space left by small molecules and biologics, allowing drug developers to address a wider range of diseases, and particularly those with limited or no therapeutic options. This has generated significant interest in this field; however, first generation molecules exhibiting potency and safety issues have hindered the potential of oligonucleotide therapies, dramatically impacting the drug development landscape. Recent advances in nucleic acid chemistry and delivery to improve stability, bioavailability, specificity and potency are now driving the rapid development and clinical evaluation of a new generation of therapies poised for success. Healthtech.com/Oligonucleotide microrna as Biomarkers and April 4-5, 2016 Cambridge, MA Recent research has shown small, non-coding micrornas to be master regulators of cellular processes, and expression patterns have revealed their potential as diagnostic, prognostic, and treatment response biomarkers. Cambridge Healthtech Institute s Twelfth Annual microrna as Biomarkers and meeting will cover the latest research in the use of micrornas for early detection of disease, monitoring cancer progression and therapeutic response, and understanding immunity. Implications for the future of personalized medicine will also be discussed. RNAconference.com/microRNA Extracellular RNA in Drug and Diagnostic Development April 5-6, 2016 Cambridge, MA Extracellular RNAs (exrnas) found in biofluids are a rich source of information about cellular processes in both health and disease. In particular, exrnas enclosed in extracellular vesicles and therefore protected from degradation, are involved in intercellular communication and may serve as diagnostic and prognostic biomarkers of cancer, cardiovascular and neurodegenerative diseases. Cambridge Healthtech Institute s Second Annual Extracellular RNA in Drug and Diagnostic Development meeting will present the latest research in this emerging area of non-invasive diagnostics, including exosomes and microvesicles, circulating microrna and other non-coding RNA, and issues of standardization, profiling, and data analysis. RNAconference.com/Extracellular-RNA March August

12 Conferences by Date with Detail Medical Informatics World April 4-5, 2016 Boston, MA Now in its fourth year, Medical Informatics World has become a must-attend industry event, uniting senior-level executives and industry leaders representing all the major contributors to a new era of healthcare. More than 400 providers, payers, technology vendors, biomedical scientists, academic researchers, informaticists and national health organizations come together to discuss emerging trends and collaborations in health IT for improved outcomes in the healthcare ecosystem. Focused tracks allow the community to delve into the most pressing topics of cross-industry data sharing, population health, patient engagement, and clinical decision support. Keeping pace with the evolving industry, coverage has now expanded to include quantitative imaging and radiomics, predictive analytics and interoperability. MedicalInformaticsWorld.com Bio-IT World Since its debut in 2002, the Annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad of IT and informatics applications and enabling technologies that drive biomedical research, drug discovery & development, and clinical and healthcare initiatives. The Bio-IT World Conference & Expo continues to be a vibrant event that unites 3,000+ life sciences, pharmaceutical, clinical, healthcare, and IT professionals from more than 30 countries. Spanning three days, the 2016 meeting includes 13 parallel conference tracks and 16 pre-conference workshops. Compelling talks, including best practice case studies and joint partner presentations, will feature over 260 of your fellow industry and academic colleagues discussing themes of big data, smart data, cloud computing, trends in IT infrastructure, omics technologies, high-performance computing, data analytics, open source and precision medicine, from the research realm to the clinical arena. Bio-ITWorldExpo.com PEGS China Summit April 5-7, 2016 Shanghai, China Companies in China are increasingly being perceived as competitors and potential partners in novel biotherapeutics development. Local conglomerates are setting up biotherapeutic arms; multi-nationals are localizing research and development; innovative returnees are starting up new biotech ventures; and universities are spinning off novel ideas and training future generations in the protein sciences. All these are making China a futile fertile ground for the growth of novel biotherapeutics. In its third year, PEGS China: Protein and Antibody Engineering & Development Summit returns to Shanghai for 3 days of inspiring presentations and case studies featuring the latest trends and future potential of China s biotech industry. This year s event comprises four content-driven conferences with over sixty global speakers, plus a new seminar on clinical & regulatory strategies for global and domestic IND and BLA filings. In addition, dedicated exhibit hall and poster viewing hours will provide invaluable opportunities for networking, dealmaking and ideas exchange. PEGSummitChina.com Molecular Europe April 4-7, 2016 Lisboa, Portugal Novel molecular-based tools are rapidly entering the clinic and creating a new paradigm in healthcare. The Fourth International Molecular Europe event will return to Lisbon this spring and feature six tracks: Prenatal Molecular, Reproductive Genetic, Circulating Tumour Cells, Circulating Cell-Free DNA, Advanced for Infectious Disease, and Point-of-Care. As the prenatal diagnostics market has demonstrated, molecular diagnostics are being applied to the clinical setting for greater speed and accuracy of healthcare delivery, while paving the way for a new era in medicine. MolecularDxEurope.com Drug Discovery Chemistry April 19-22, 2016 San Diego, CA Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program according to personal interests. New for 2016 will be the addition of three symposia on Friday covering the blood-brain barrier, biophysical approaches for drug discovery, and antivirals. DrugDiscoveryChemistry.com PEGS: The Essential Protein Engineering Summit April 25-29, 2016 Boston, MA With record-breaking attendance in 2015, PEGS Boston attracts an international delegation of nearly 2,000 participants including conference delegates, speakers, exhibitors, sponsors and guests representing over 30 countries. Participants value the in-depth short courses, access to 22 conferences, and wide-ranging presentations delivering new unpublished data, case studies, innovation and insight. The vast exhibit hall will be packed with 125 exhibiting companies and more than 200 research posters on display providing valuable viewing of innovative new technologies, as well as abundant networking with biopharma researchers and industry representatives. PEGSummit.com Clinical Trial Innovation Summit May 9-11, 2016 Boston, MA Cambridge Healthtech Institute s Fifth Annual Clinical Trial Innovation Summit will bring together leaders from across pharma, biotech and academia to share case studies and best practices on effective clinical trial management and vendor oversight. The 2016 program focuses on key issues and opportunities in the clinical trial industry, including Data Integration, Existing Data Sources, Mobile Tech, Project Management, Outsourcing, Vendor Management, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring and Clinical Auditing. ClinicalTrialSummit.com Strategic Alliance Management Congress May 16-18, 2016 Philadelphia, PA Cambridge Healthtech Institute s 13th Annual Strategic Alliance Management Congress brings together senior alliance management, business development, technology transfer and licensing professionals, to network, share experiences, discuss case studies, and to share the components that cultivate successful partnerships. Delegates will gain strategic insights, proven tools, methods, and perspectives from a variety of leaders advancing the art of alliance management. Healthtech.com/Strategic-Alliance-Management-Congress LIFE SCIENCE MEDIA LIBRARY Continue Your Education with CHI s Digital Courses Navigate, pause, rewind and listen to recorded sessions in a multimedia presentation. Visit CHI s Life Science Media Library to view over 120 digital courses recorded at our most successful events. Formats available: Digital Download On Demand DVD Order Today Healthtech.com/MediaLibrary 12 Cambridge Healthtech Institute

13 Conferences by Date with Detail Biomarkers & World Congress May 17-19, 2016 Philadelphia, PA Cambridge Healthtech Institute s Twelfth Annual Biomarkers & World Congress 2016 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. Now in its twelfth year, the Biomarkers & World Congress is the leading annual meeting dedicated to biomarker and diagnostics research and implementation that consistently delivers a cutting-edge agenda, 400+ senior delegates, and a sold-out exhibit hall. The World Congress will continue offering comprehensive coverage of biomarkers, including translational biomarkers in drug discovery, patient selection biomarkers, strategies to co-develop drugs with companion diagnostics, cell-free DNA and RNA, as well as coverage of big data for personalized medicine. New additions this year will include a track on Biomarkers for Cancer Immunotherapy, as well as two pre-conference symposia, covering nextgeneration sequencing and exosomes. BiomarkerWorldCongress.com World Preclinical Congress June 14-17, 2016 Boston, MA In recent years, the World Preclinical Congress (WPC) has turned into a key networking event for those involved in preclinical research. It features conferences, training seminars and short courses that cover the very latest in preclinical strategies and technologies, to enable better and faster decisions in drug discovery. WPC attracts a diverse, global audience, which include experts, as well as people who are new and eager to contribute to the field. Having chemists, biologists, pharmacologists, toxicologists, screening and formulation experts in attendance, creates an interesting cross-disciplinary environment for tackling challenges and sharing expertise. Now in its 15th year the event will continue to highlight ways to improve accuracy and efficiency in preclinical research, while bringing together the people and technologies to make it happen. As always, we ask those of you involved in preclinical work to try and help innovate traditional drug discovery by bringing along your ideas, showcasing new technologies, and fostering new collaborations. WPC is indeed the event Where Preclinical Minds Meet Discovery Technologies and we hope you can join this dynamic community to help shape the future of preclinical research! WorldPreclinicalCongress.com The Liquid Biopsy Summit June 22-24, 2016 San Francisco, CA This is an unprecedented time in biomolecular medicine. Recent scientific findings have determined biofluids consist of circulating cell-free (cf)dna and extracellular (ex)rna from multiple tissues within the body. In addition, the rapid development of highly sensitive and accurate next-generation sequencing (NGS) technologies has empowered researchers to analyze the role of these biomolecules in health, disease and treatment response. However, there remains considerable insecurity associated with biofluid-based DNA/RNA analytical methods which must be solved before liquid biopsies can be implemented for broader routine applications. With refinements in the process and technology, molecular liquid biopsies have the potential to become a fulcrum in the future of precision medicine. LiquidBiopsySummit.com Biodefense World Summit June 27-30, 2016 Baltimore, MD The Knowledge Foundation s Second Annual Biodefense World Summit brings together leaders from government, academia, and industry for compelling discussions and comprehensive coverage on pathogen detection, sample prep technologies, point-of-care, and biosurveillance. Across the four-track event, attendees can expect exceptional networking opportunities in the exhibit hall, across panel discussions, and shared case studies with members of the biodefense community from technology providers to policy makers. BiodefenseWorldSummit.com The Bioprocessing Summit August 15-19, 2016 Boston, MA The Bioprocessing Summit brings together international leaders to discuss today s bioprocess issues from cell line selection to bioproduction. The Summit provides practical details in a relaxed, congenial atmosphere that promotes information exchange and networking. This leading bioprocess meeting is hosted in Boston each summer along the lively and cosmopolitan harbor waterfront. Each year, the international bioprocessing community comes together at the Summit to share practical solutions for today s bioprocess challenges with researchers from around the world. Spanning five days, the 2016 meeting includes 16 conference programs, 9 training seminars, and 10 short courses. BioprocessingSummit.com Next Generation Dx Summit August 23-26, 2016 Washington, DC Next Generation Dx Summit convenes more than 1,000 international diagnostic professionals for valuable networking and comprehensive programming spanning from clinical diagnostics to business strategy. Now in its eighth year, the event has grown to include novel immunotherapy biomarkers, cell-free DNA, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, commercialization, and reimbursement. New programming in 2016 includes prenatal diagnostics, circulating tumor cells, forensics, telemedicine and microbiome sequencing. The Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important issues for the industry. NextGenerationDx.com The Immuno-Oncology Summit Aug. 24-Sept. 2, 2016 Boston, MA As our understanding of tumor immunology has advanced, immunooncology has made unprecedented progress in improving the outcomes for cancer patients. Still, with the field in its infancy, the full curative potential of IO has yet to be realized. CHI s 4th Annual Immuno-Oncology Summit has been designed to support a coordinated effort by industry players to bring commercial immunotherapies and immunotherapy combinations through clinical development and into the market. This weeklong, nine-meeting set will include topics ranging from early discovery through clinical development as well as emerging areas such as oncolytic virotherapy. Overall, this event will provide a focused look at how researchers are applying new science and technology in the development of the next generation of effective and safe immunotherapies. Immuno-OncologySummit.com March August

14 Short Course Schedule HOLD A COURSE AT YOUR FACILITY. For more information, please contact Edel O Regan at or eoregan@healthtech.com MOLECULAR MEDICINE TRI-CONFERENCE March 6-10, 2016 San Francisco, CA BIO-IT WORLD April 5, 2016 Boston, MA -- Translating CTCs to Clinical Use -- Handling Troubled Projects -- Microbiome: Sorting Out the Hype from the Hope -- Intelligent Methods Optimization of Algorithms for NGS -- NGS Assay Selection, Validation and Compliance -- Visualization for Biomedical Data Analysis: From the Basics to -- Sequencing 101 Applications -- Through the Molecular Looking Glass of High-Resolution Melting -- Data Management for Biologics: Registration and Beyond -- Reimbursement for Advanced : From Clinical Value Establishment to Coding, Coverage and Pricing -- Clinical Informatics: Returning Results from Big Data 14 Cambridge Healthtech Institute -- Security Considerations for Virtual Research -- Opportunities and Challenges of Mobile Health, Wearables, and Sensors for Pharma -- Development of Bioassays for Checkpoint Immunotherapy -- Innovation and Patient-Centricity -- Regulatory Compliance in Molecular -- Creating a Best of Breed Informatics Environment for your -- Digital PCR: Applications and Advances Organization -- Liquid Biopsy Technologies Overview -- Growth Strategy: Leveraging Cloud Scalability to Enable Rapid -- Applications in Telemedicine Growth and Change -- Commercialization Boot Camp: Manual for Success in Molecular -- iconquerms : A Patient-Centered Research Model -- Determining Genome Variation and Clinical Utility -- Next-Generation Sequencing as a Platform -- Data Science Driving Better Informed Decisions -- Isolation and Characterization of Cancer Stem Cells -- DNA for Data Storage -- Translating Preclinical Data in the Rational Design of Cancer Combination Therapies -- Designing Storage Solutions for Life Sciences -- Best Practices in Personalized and Translational Medicine DRUG DISCOVERY CHEMISTRY -- NGS for Infectious Disease April 18-20, 2016 San Diego, CA -- Metabolic Microbiome -- Trends in Physical Properties of Drugs -- Detection and Characterization of Circulating Biomarkers -- GPCR Structure-Based Drug Discovery -- A Primer to Gene Editing: Tools and Applications -- Designing Peptide Therapeutics for Specific PPIs CANCER BIOTHERAPEUTICS March 15, 2016 London, UK -- Immunology Basics for Chemists -- Phenotypic Screening and Chemical Probe Development -- Crystallography for Drug Design -- Cancer Immunotherapy -- Ligand-Receptor Molecular Interactions and Drug Design -- Engineering and Optimisation of Antibody Products -- Inhibitor Design using MOE SBDD Applications -- Enabling Macrocyclic Compounds for Drug Discovery: BIOTHERAPEUTICS ANALYTICAL SUMMIT Opportunities, Challenges and Strategies March 15, 2016 Bethesda, MD -- Advancing Tools and Technologies for Fragment-Based Design -- SVPs, Aggregates and Impurities: Measurement, Characterization, and Impact -- Introduction to Targeted Covalent Inhibitors -- Glycobiology of Antibodies PEGS BOSTON -- New Analytical Approaches & Strategies for Comparability and April 24-29, 2016 Boston, MA Biosimilarity -- Fluorescent Proteins in Protein Engineering -- Bioanalytical Considerations of Multi-Domain Biotherapeutics: OLIGONUCLEOTIDE THERAPEUTICS AND DELIVERY Preclinical and Clinical Development April 3, 2016 Cambridge, MA -- Antibody Humanization via One Hot Homology Model Workshop -- Oligonucleotide Therapeutics: From Discovery to Manufacturing -- Translational Considerations for Development of Monoclonal Antibodies: Focus on Early Discovery (Part I) MICRORNA AS BIOMARKERS & DIAGNOSTICS -- Immunogenicity Risk Assessment and Regulatory Strategies EXTRACELLULAR RNA IN DRUG & DIAGNOSTIC DEVELOPMENT April 3-5, 2016 Cambridge, MA -- Data Normalization Challenges and Solutions -- In silico Immunogenicity Predictions Workshop -- Translational Considerations for Development of Monoclonal Antibodies: Focus on Nonclinical Development to Clinic (Part II) -- microrna-based Therapeutics -- Next-Generation Sequencing of Antibody Libraries: Details -- micrornas in the Immune Response on Experimental and Bioinformatic Methods